Results 211 to 220 of about 30,146 (272)

A case displaying the importance of JAK1 and JAK2 gene transcription in antifungal defense against coccidioidomycosis. [PDF]

Front Med (Lausanne)
Priessnitz JK, Colore T, Nicolasora N.
europepmc   +1 more source

Two Years On: How Ruxolitinib is Shaping the Practical Management of Vitiligo [PDF]

Samantha Stanbury
openalex   +1 more source

Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo. [PDF]

Dermatol Ther (Heidelb)
Rosmarin D, Pandya AG, Passeron T, Forman SB, Zdybski J, Amster M, Feser C, Papp KA, Nuara A, Kornacki D, Wei S, Ren H, Harris JE, Ezzedine K.   +13 more
europepmc   +1 more source

Improvement of Suspected Linear Morphea seen with Topical Ruxolitinib

S. Abu Amara, Mildrey Jiménez López, Mark Lebwohl   +2 more
openalex   +2 more sources

[Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells].

, 2017
Gaigai Liu, L J Zhang, Jiayao Fu, W T Liang, Zhen Cheng, Peide Bai, Yaoyao Bian, Jie Wan   +7 more
openalex   +2 more sources

LL37-driven mast cell degranulation and inflammation in rosacea via TLR2/JAK2/STAT3 axis. [PDF]

Front Immunol
Fan H, Sun R, Ma Q, Li X, Liu J, Zhang M, Xu C, Zhang D, Ma W.   +8 more
europepmc   +1 more source

PS1243 JAK‐INHIBITION WITH RUXOLITINIB IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A PHASE II, OPEN LABEL, MULTICENTER CLINICAL TRIAL (JERICHO)

, 2019
Silke Gillessen, Annette Pluetschow, Vladan Vučinić, Helmut Ostermann, Carsten Kobe, Paul Broeckelmann, Michael Fuchs, Jesko Momotow, Peter Borchmann, Andreas Engert, Bastian von Tresckow   +10 more
openalex   +1 more source

Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication. [PDF]

Ther Adv Chronic Dis
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K.   +13 more
europepmc   +1 more source